Biotechnology News

August 31, 2012

NEWTON, Mass.--(BUSINESS WIRE)--Galectin Therapeutics is relocating its corporate headquarters to Atlanta, GA.

August 31, 2012

RIDGEFIELD, Conn. & NEW YORK--(BUSINESS WIRE)--Boehringer Ingelheim and Pfizer Inc (NYSE: PFE) announced today three scientific data presentations will take place at the 2012 European Respiratory Society (ERS) Congress in Vienna, Austria,...

August 31, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: The Extraordinary General Meeting of Vitrolife AB (publ)(STO:VITR) will take place on Monday September 24, 2012, at 3 p.m. in the company’s premises at Gustaf Werners gata 2 in Gothenburg....

August 31, 2012

LUND, Sweden--(BUSINESS WIRE)--Regulatory News: The Probi (STO:PROB) probiotic company, which is listed on the Nasdaq OMX Nordic Exchange Stockholm, has gained a new industrial shareholder in the German company Symrise. Symrise has acquired a...

August 31, 2012

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine: (STO:AERO.B) With reference to Chapter 4 Section 9 in ”lagen (1991:980) om handel med finansiella instrument” it’s hereby announced that through the subscription by exercise of options...

August 31, 2012

SYDNEY--(BUSINESS WIRE)--GenesisCare shareholders have voted unanimously in favour of affiliates of Kohlberg Kravis Roberts & Co. L.P. (together with its affiliates, "KKR") entering into an agreement whereby KKR will own a 49.6 per cent of...

August 30, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from Baird’s 2012 Healthcare Conference in New York. Norbert Bischofberger, PhD, Gilead’s Executive Vice...

August 30, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ: EXEL) announced today that Michael M. Morrissey, Ph.D., the company’s president and chief executive officer, will present at three upcoming investor conferences. Stifel...

August 30, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the Stifel Nicolaus Annual Healthcare Conference in Boston on Thursday, September 6, 2012 at 8:35 a.m. ET. The presentation will be available as a live...

August 30, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Baird 2012 Health Care Conference on Thursday, Sept. 6, 2012, at 11:20 a.m. EDT (4:20 p.m. BST) in New York City. In...

August 30, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Forest Laboratories, Inc. (NYSE: FRX) will be hosting a conference call to discuss the U.S. Food and Drug Administration (FDA) approval of LINZESS™ at 4:00 p.m....

August 30, 2012

MADISON, Wis.--(BUSINESS WIRE)--Six Wisconsin bioscience companies have been selected as the winners of BioForward’s 2012 Emerging Company Showcase. The showcase is part of the 2012 Bioscience Vision Summit, being held on Sept 12.

August 30, 2012

CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Forest Laboratories, Inc. (NYSE: FRX) announced today that LINZESS™ (linaclotide) was approved by the U.S. Food and Drug Administration (FDA) as a...

August 30, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the realignment of its product divisions into two new operating units: the Implantable Electronic Systems Division (IESD) and...

August 30, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Acquires Biopharmaceutical Company

August 30, 2012

BETHESDA, Md.--(BUSINESS WIRE)--Mid-Atlantic Bio today opened BioMatch to all registered conference attendees. BioMatch is the business networking tool for the conference and allows attendees to share information with each other.

August 30, 2012

CLEVELAND--(BUSINESS WIRE)--Cleveland HeartLab today announced three additions to its team that will enable the company to continue to set new standards of growth, customer service and innovation.

August 30, 2012

PARIS--(BUSINESS WIRE)--Cegedim Relationship Management, the worldwide expert in healthcare compliance solutions for the Life Sciences, today announced a collaboration with UK-based international law firm, Clifford Chance. Through the...

August 30, 2012

SAN ANTONIO--(BUSINESS WIRE)--KCI Leads Educational Effort to Improve Patient Care Worldwide, World Union of Wound Healing Societies Commitment Includes Access to Review Articles on Recent Evolution of NPWT

August 30, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that for those surveyed rheumatoid arthritis (RA) patients on biologic therapy, the...

August 30, 2012

BILLERICA, Mass.--(BUSINESS WIRE)--EMD Millipore has donated $10,000 to charity: water- a non-profit organization focused on bringing clean and safe drinking water to people in developing nations.

August 30, 2012

WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Xylem applauds International Stockholm Junior Water Prize awardee for research to use clay to remove and recover pollutants from wastewater

August 30, 2012

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. announced that the company will present at the Baird Health Care and UBS Global Life Sciences Conferences during September.

August 30, 2012

CINCINNATI--(BUSINESS WIRE)--Aerpio Therapeutics has closed a $27 million Series A to develop its first-in-class activator of Tie2 for the treatment of diabetic macular edema.

August 30, 2012

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that Stephen M. Simes, BioSante’s president & CEO, will present a corporate update at the Stifel Nicolaus Healthcare Conference and Rodman...

August 30, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Top-performing medical science liaison teams leverage their MSLs’ positions in the medical community to continuously update thought leader databases, according to a new study.

August 30, 2012

WOBURN, Mass.--(BUSINESS WIRE)--ArQule will present at three upcoming investment conferences.

August 30, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that David Perry, the company’s Chief Executive Officer, will provide a company overview at the Stifel Nicolaus 2012 Healthcare Conference on Wednesday,...

August 30, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. announced that Tetraphase President & Chief Executive Officer Guy Macdonald will present at the Stifel Nicolaus 2012 Healthcare Conference on September 5, 2012

August 30, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) announced today that executive management will participate in the Rodman & Renshaw Annual Global Investment Conference, being held September 10-11, 2012 at The Waldorf Astoria in...

August 30, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the Stifel Nicolaus Healthcare Conference on September 5, 2012 at 1:30 p.m. ET in Boston. In addition, Infinity will be presenting at the...

August 30, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage biopharmaceutical company focused on developing multi-indication therapeutics in oncology and CNS, today announced that it will present at the Stifel...

August 30, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem will present at several upcoming investment conferences.

August 30, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the submission of a Marketing Authorization Application (MAA) for its investigational BCR-ABL inhibitor, ponatinib, to the European Medicines Agency (...

August 30, 2012

AARHUS, Denmark--(BUSINESS WIRE)--CLC bio, the world's leading bioinformatics software developer, has been awarded a share of a EU-funded clinical research grant, PATHSEEK, worth $ 2M out of a total project budget of $ 10M.

August 30, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals will present at the Stifel Nicolaus Healthcare Conference and BioCentury’s 19th Annual NewsMakers in the Biotech Industry conference.

August 30, 2012

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Completes Enrollment in Phase 1b Trial of RNAi Drug Candidate CALAA-01

August 30, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm announced that Igor Gonda, Aradigm’s CEO, will be a panel member at the FDA’s public workshop on the design of clinical trials of antibacterial drugs for non-cystic fibrosis bronchiectasis

August 30, 2012

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Paul K. Wotton, Ph.D., President and Chief Executive Officer, will present at the Stifel Nicolaus 2012 Healthcare Conference on Thursday, September 6, 2012 at...

August 30, 2012

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals Announces One-to-One Conversion of Class B Common Stock into Class A Common Stock

August 30, 2012

SANTA ANA, Calif.--(BUSINESS WIRE)--MP Biomedicals, LLC, a leading provider of life science reagents, fine chemicals and diagnostic products for over 50 years, announced today it has launched a new website.

August 30, 2012

SYDNEY--(BUSINESS WIRE)--Sirtex Medical Limited, ASX:SRX, revenue growth, biotechnology, medical technology, liver cancer, oncology.

August 30, 2012

IRVINE, Calif. & LIEGE, Belgium--(BUSINESS WIRE)--Regulatory News: MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, announced today its...

August 30, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Elekta (STO:EKTAB) has won a major tender where the Health Department of the People’s Liberation Army (PLA) is expanding its capacity to treat cancer. Cancer is one of the leading causes of death in...

August 30, 2012

TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that A. Collier Smyth, Gerhard Waldheim and Wayne P. Yetter have resigned from the Company’s Board of Directors...

August 29, 2012

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec to Present at Stifel Nicolaus Healthcare Conference

August 29, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ: EXEL) today was notified by the Food and Drug Administration (the “FDA”) that the Company’s new drug application (“NDA”) for cabozantinib as a treatment for patients with...